Gene · 4192
Papers2,993
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 2,993
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Midkine and pleiotrophin in glioma: From mechanistic insights to therapeutic potential. | Neoplasia | 2026 | 41955968 | PubTator, text mining | PubMed |
| OLFM4 orchestrates the immunosuppressive microenvironment and drives gallbladder cancer progression. | J Cancer Res Clin Oncol | 2026 | 41934482 | PubTator, text mining | PubMed |
| Integrated single‑cell and spatial transcriptomics reveal the colorectal cancer microenvironment. | Crit Rev Oncol Hematol | 2026 | 41933856 | PubTator, text mining | PubMed |
| Combined Antineoplastic Effects of Metformin, Boric Acid and Resveratrol in SKOV3 Ovarian Cancer Cells. | Biomedicines | 2026 | 41898364 | PubTator, text mining | PubMed |
| Urine-Based Approaches for Screening, Diagnosis, and Surveillance of Urothelial Carcinoma. | J Pers Med | 2026 | 41893002 | PubTator, text mining | PubMed |
| Translating Fibrosis to Malignancy: Biomarkers and Therapeutic Opportunities in Liver Fibrosis and Hepatocellular Carcinoma. | Med Sci (Basel) | 2026 | 41892825 | PubTator, text mining | PubMed |
| Advances in Spatial Multi-Omics in Gastric Cancer. | Cells | 2026 | 41892326 | PubTator, text mining | PubMed |
| Synthesis of Sulfated Glycomimetics with Micromolar Affinity for Midkine. | J Org Chem | 2026 | 41891761 | PubTator, text mining | PubMed |
| Novel Midkine-Derived Peptide Promotes Reparative Dentine Formation via DDIT4/mTOR Pathway-Mediated Activation of Autophagy. | Int Endod J | 2026 | 41877659 | PubTator, text mining | PubMed |
| Serum Midkine as a Potential Biomarker Associated with Disease Severity and Remodeling-Related Mediators in Children with Asthma. | J Asthma Allergy | 2026 | 41868537 | PubTator, text mining | PubMed |
| Single-cell dissection of pleural and systemic immunity uncovers pathogen-specific immune reprogramming in tuberculosis versus lung adenocarcinoma. | Inflamm Res | 2026 | 41865158 | PubTator, text mining | PubMed |
| Multi-omics profiling identifies ectopic olfactory receptors as putative drivers of tumor progression and prognostic indicators in clear cell renal cell carcinoma. | Clin Exp Med | 2026 | 41863682 | PubTator, text mining | PubMed |
Isolation methods influence the biological properties of Wharton's Jelly-derived mesenchymal stem cells: A comparative study of yield, viability, proliferation, differentiation potential, and proteomic profiles. | PLoS One | 2026 | 41860834 | PubTator, text mining | PubMed |
| ENS lineage potential is not intrinsically regionalized but is modulated by PTPRZ1 signaling. | bioRxiv | 2026 | 41846962 | PubTator, text mining | PubMed |
| BGN/MDK Axis in the Melanoma Tumor Microenvironment Strengthens Tumor Malignancy by Modulating Cancer Cells and Cancer-Associated Fibroblasts Crosstalk. | Adv Sci (Weinh) | 2026 | 41833003 | PubTator, text mining | PubMed |
| Collagen II hydrogel-mediated sustained delivery of lacosamide attenuates cartilage degeneration and pain in osteoarthritis. | Bioact Mater | 2026 | 41799961 | PubTator, text mining | PubMed |
| Identification of programmed cell death-related subtypes reveals immune heterogeneity and therapeutic divergence in colon cancer. | Theranostics | 2026 | 41799193 | PubTator, text mining | PubMed |
| Anaplastic Lymphoma Kinase (ALK)-Positive Large B-cell Lymphoma in Children: A Case Report and Review of Literature. | Cureus | 2026 | 41798535 | PubTator, text mining | PubMed |
| Spatially defined danger zone shapes gastric cancer progression through CCDC80+ fibroblast-induced CD8+ T cell dysfunction. | Apoptosis | 2026 | 41793512 | PubTator, text mining | PubMed |
| Dynamic transcriptomic remodeling in grafted human neural progenitor cells uncovers mechanisms for vision preservation in a rat model of retinitis pigmentosa. | Nat Commun | 2026 | 41792118 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4192/papers?page=4